Whole genome sequencing facilitates intragenic variant interpretation following modifier screening in C. elegans.

Abstract excerpt

BACKGROUND: Intragenic modifiers (in-phase, second-site variants) are known to have dramatic effects on clinical outcomes, affecting disease attributes such as severity or age of onset. However, despite their clinical importance, the focus of many genetic screens in model systems is on the discovery of extragenic variants, with many labs still relying upon more traditional methods to identify modifiers. However,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Alleles
• Share to Caenorhabditis elegans